HOW CAN WE IMPROVE SYMPTOM CONTROL AND QUALITY OF LIFE IN IBS PATIENTS? – INSIGHTS INTO THE ROLE OF LOW-FODMAP DIET, PHYSICAL ACTIVITY, AND OTHER KEY LIFESTYLE DETERMINANTS
Abstract
Introduction, purpose: Irritable bowel syndrome (IBS) is a prevalent functional gastrointestinal disorder marked by chronic abdominal pain and altered bowel habits without clear structural abnormalities. It often coexists with psychological distress and lifestyle-related challenges, significantly reducing patients’ quality of life. This paper explores dietary, physical, psychological, and environmental factors that influence IBS symptom severity and progression, with emphasis on their impact on well-being.
Key topics include the role of diet—particularly the low-FODMAP approach—and its effects on symptom relief and gut microbiota, as well as potential risks like nutrient deficiencies. The analysis also considers the benefits of regular physical activity, not only in reducing symptoms but in improving mood and quality of life. Additionally, links between poor sleep, chronic stress, and alcohol intake are addressed.
Materials and methods: A systematic literature review was conducted using the PubMed database to explore the current state of knowledge regarding IBS, with particular focus on impact of lifestyle.
Conclusion: The findings underscore the importance of a multidisciplinary approach to IBS treatment, integrating both clinical and lifestyle strategies. Personalized dietary interventions, regular physical activity, effective stress management, adequate sleep, and moderation in alcohol intake should be viewed as essential, not optional, components of care. Together, these elements offer a comprehensive strategy that not only improves symptom control but also supports long-term health and enhances patients’ overall quality of life.
References
Defrees, D. N., & Bailey, J. (2017). Irritable Bowel Syndrome: Epidemiology, Pathophysiology, Diagnosis, and Treatment. Primary care, 44(4), 655–671. https://doi.org/10.1016/j.pop.2017.07.009.
Raskov, H., Burcharth, J., Pommergaard, H. C., & Rosenberg, J. (2016). Irritable bowel syndrome, the microbiota and the gut-brain axis. Gut microbes, 7(5), 365–383. https://doi.org/10.1080/19490976.2016.1218585
Radovanovic-Dinic, B., Tesic-Rajkovic, S., Grgov, S., Petrovic, G., & Zivkovic, V. (2018). Irritable bowel syndrome - from etiopathogenesis to therapy. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 162(1), 1–9. https://doi.org/10.5507/bp.2017.057
Talley, N. J., Gabriel, S. E., Harmsen, W. S., Zinsmeister, A. R., & Evans, R. W. (1995). Medical costs in community subjects with irritable bowel syndrome. Gastroenterology, 109(6), 1736–1741. https://doi.org/10.1016/0016-5085(95)90738-6
Ford, A. C., Sperber, A. D., Corsetti, M., & Camilleri, M. (2020). Irritable bowel syndrome. Lancet (London, England), 396(10263), 1675–1688. https://doi.org/10.1016/S0140-6736(20)31548-8
Abhari, K., Saadati, S., Hosseini-Oskouiee, F., Yari, Z., Hosseini, H., Sohrab, G., Hejazi, E., Agah, S., Sadeghi, A., & Hekmatdoost, A. (2020). Is Bacillus coagulans supplementation plus low FODMAP diet superior to low FODMAP diet in irritable bowel syndrome management?. European journal of nutrition, 59(5), 2111–2117. https://doi.org/10.1007/s00394-019-02060-y
Bonetto, S., Fagoonee, S., Battaglia, E., Grassini, M., Saracco, G. M., & Pellicano, R. (2021). Recent advances in the treatment of irritable bowel syndrome. Polish archives of internal medicine, 131(7-8), 709–715. https://doi.org/10.20452/pamw.16067
Vedantam, S., Graff, E., Khakoo, N. S., Khakoo, N. S., & Pearlman, M. (2023). Food as Medicine: How to Influence the Microbiome and Improve Symptoms in Patients with Irritable Bowel Syndrome. Current gastroenterology reports, 25(3), 52–60. https://doi.org/10.1007/s11894-023-00861-0
Algera, J., Colomier, E., & Simrén, M. (2019). The Dietary Management of Patients with Irritable Bowel Syndrome: A Narrative Review of the Existing and Emerging Evidence. Nutrients, 11(9), 2162. https://doi.org/10.3390/nu11092162
Rej A, Avery A, Aziz I, et al. Diet and irritable bowel syndrome: an update from a UK consensus meeting. BMC Med. 2022;20(1):287. Published 2022 Sep 13. doi:10.1186/s12916-022-02496-w
Black, C. J., Staudacher, H. M., & Ford, A. C. (2022). Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut, 71(6), 1117–1126. https://doi.org/10.1136/gutjnl-2021-325214
Gibson, P. R., & Shepherd, S. J. (2005). Personal view: food for thought--western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis. Alimentary pharmacology & therapeutics, 21(12), 1399–1409. https://doi.org/10.1111/j.1365-2036.2005.02506.x
Gibson, P. R., Halmos, E. P., & Muir, J. G. (2020). Review article: FODMAPS, prebiotics and gut health-the FODMAP hypothesis revisited. Alimentary pharmacology & therapeutics, 52(2), 233–246. https://doi.org/10.1111/apt.15818
Sultan, N., Varney, J. E., Halmos, E. P., Biesiekierski, J. R., Yao, C. K., Muir, J. G., Gibson, P. R., & Tuck, C. J. (2022). How to Implement the 3-Phase FODMAP Diet Into Gastroenterological Practice. Journal of neurogastroenterology and motility, 28(3), 343–356. https://doi.org/10.5056/jnm22035
Eswaran, S., Dolan, R. D., Ball, S. C., Jackson, K., & Chey, W. (2020). The Impact of a 4-Week Low-FODMAP and mNICE Diet on Nutrient Intake in a Sample of US Adults with Irritable Bowel Syndrome with Diarrhea. Journal of the Academy of Nutrition and Dietetics, 120(4), 641–649. https://doi.org/10.1016/j.jand.2019.03.003
Gwioździk, W., Krupa-Kotara, K., Całyniuk, B., Helisz, P., Grajek, M., & Głogowska-Ligus, J. (2022). Traditional, Vegetarian, or Low FODMAP Diets and Their Relation to Symptoms of Eating Disorders: A Cross-Sectional Study among Young Women in Poland. Nutrients, 14(19), 4125. https://doi.org/10.3390/nu14194125
Bhattarai, Y., Muniz Pedrogo, D. A., & Kashyap, P. C. (2017). Irritable bowel syndrome: a gut microbiota-related disorder?. American journal of physiology. Gastrointestinal and liver physiology, 312(1), G52–G62. https://doi.org/10.1152/ajpgi.00338.2016
Oriach, C. S., Robertson, R. C., Stanton, C., Cryan, J. F., & Dinan, T. G. (2016). Food for thought: The role of nutrition in the microbiota-gut–brain axis. Clinical Nutrition Experimental, 6, 25-38.
Berding, K., Vlckova, K., Marx, W., Schellekens, H., Stanton, C., Clarke, G., Jacka, F., Dinan, T. G., & Cryan, J. F. (2021). Diet and the Microbiota-Gut-Brain Axis: Sowing the Seeds of Good Mental Health. Advances in nutrition (Bethesda, Md.), 12(4), 1239–1285. https://doi.org/10.1093/advances/nmaa181
Ribeiro, G., Ferri, A., Clarke, G., & Cryan, J. F. (2022). Diet and the microbiota - gut - brain-axis: a primer for clinical nutrition. Current opinion in clinical nutrition and metabolic care, 25(6), 443–450. https://doi.org/10.1097/MCO.0000000000000874
Wachsmuth, H. R., Weninger, S. N., & Duca, F. A. (2022). Role of the gut-brain axis in energy and glucose metabolism. Experimental & molecular medicine, 54(4), 377–392. https://doi.org/10.1038/s12276-021-00677-w
Drossman D. A. (2016). Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. Gastroenterology, S0016-5085(16)00223-7. Advance online publication. https://doi.org/10.1053/j.gastro.2016.02.032
Enck, P., Aziz, Q., Barbara, G., Farmer, A. D., Fukudo, S., Mayer, E. A., Niesler, B., Quigley, E. M., Rajilić-Stojanović, M., Schemann, M., Schwille-Kiuntke, J., Simren, M., Zipfel, S., & Spiller, R. C. (2016). Irritable bowel syndrome. Nature reviews. Disease primers, 2, 16014. https://doi.org/10.1038/nrdp.2016.14
Hillestad, E. M. R., van der Meeren, A., Nagaraja, B. H., Bjørsvik, B. R., Haleem, N., Benitez-Paez, A., Sanz, Y., Hausken, T., Lied, G. A., Lundervold, A., & Berentsen, B. (2022). Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome. World journal of gastroenterology, 28(4), 412–431. https://doi.org/10.3748/wjg.v28.i4.412
Sadeghian, M., Sadeghi, O., Hassanzadeh Keshteli, A., Daghaghzadeh, H., Esmaillzadeh, A., & Adibi, P. (2018). Physical activity in relation to irritable bowel syndrome among Iranian adults. PloS one, 13(10), e0205806. https://doi.org/10.1371/journal.pone.0205806
Sullivan, S. N., Wong, C., & Heidenheim, P. (1994). Does running cause gastrointestinal symptoms? A survey of 93 randomly selected runners compared with controls. The New Zealand medical journal, 107(984), 328–331.
Daley, A. J., Grimmett, C., Roberts, L., Wilson, S., Fatek, M., Roalfe, A., & Singh, S. (2008). The effects of exercise upon symptoms and quality of life in patients diagnosed with irritable bowel syndrome: a randomised controlled trial. International journal of sports medicine, 29(9), 778–782. https://doi.org/10.1055/s-2008-1038600
Kang, S. H., Choi, S. W., Lee, S. J., Chung, W. S., Lee, H. R., Chung, K. Y., Lee, E. S., Moon, H. S., Kim, S. H., Sung, J. K., Lee, B. S., & Jeong, H. Y. (2011). The effects of lifestyle modification on symptoms and quality of life in patients with irritable bowel syndrome: a prospective observational study. Gut and liver, 5(4), 472–477. https://doi.org/10.5009/gnl.2011.5.4.472
Johannesson, E., Simrén, M., Strid, H., Bajor, A., & Sadik, R. (2011). Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial. The American journal of gastroenterology, 106(5), 915–922. https://doi.org/10.1038/ajg.2010.480
Johannesson, E., Ringström, G., Abrahamsson, H., & Sadik, R. (2015). Intervention to increase physical activity in irritable bowel syndrome shows long-term positive effects. World journal of gastroenterology, 21(2), 600–608. https://doi.org/10.3748/wjg.v21.i2.600
Nunan, D., Cai, T., Gardener, A. D., Ordóñez-Mena, J. M., Roberts, N. W., Thomas, E. T., & Mahtani, K. R. (2022). Physical activity for treatment of irritable bowel syndrome. The Cochrane database of systematic reviews, 6(6), CD011497. https://doi.org/10.1002/14651858.CD011497.pub2
Konturek, P. C., Brzozowski, T., & Konturek, S. J. (2011). Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 62(6), 591–599.
Larauche, M., Mulak, A., & Taché, Y. (2012). Stress and visceral pain: from animal models to clinical therapies. Experimental neurology, 233(1), 49–67. https://doi.org/10.1016/j.expneurol.2011.04.020
Larauche, M., Mulak, A., & Taché, Y. (2011). Stress-related alterations of visceral sensation: animal models for irritable bowel syndrome study. Journal of neurogastroenterology and motility, 17(3), 213–234. https://doi.org/10.5056/jnm.2011.17.3.213
Grenham, S., Clarke, G., Cryan, J. F., & Dinan, T. G. (2011). Brain-gut-microbe communication in health and disease. Frontiers in physiology, 2, 94. https://doi.org/10.3389/fphys.2011.00094
O'Malley, D., Quigley, E. M., Dinan, T. G., & Cryan, J. F. (2011). Do interactions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome?. Brain, behavior, and immunity, 25(7), 1333–1341. https://doi.org/10.1016/j.bbi.2011.04.009
Barbara, G., Stanghellini, V., Cremon, C., De Giorgio, R., & Corinaldesi, R. (2008). What is the effect of inflammation on intestinal function?. Inflammatory bowel diseases, 14 Suppl 2, S140–S144. https://doi.org/10.1002/ibd.20701
Sturiale, S., Barbara, G., Qiu, B., Figini, M., Geppetti, P., Gerard, N., Gerard, C., Grady, E. F., Bunnett, N. W., & Collins, S. M. (1999). Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P. Proceedings of the National Academy of Sciences of the United States of America, 96(20), 11653–11658. https://doi.org/10.1073/pnas.96.20.11653
Bonfrate, L., Tack, J., Grattagliano, I., Cuomo, R., & Portincasa, P. (2013). Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Scandinavian journal of gastroenterology, 48(9), 995–1009. https://doi.org/10.3109/00365521.2013.799220
Dekel, R., Drossman, D. A., & Sperber, A. D. (2013). The use of psychotropic drugs in irritable bowel syndrome. Expert opinion on investigational drugs, 22(3), 329–339. https://doi.org/10.1517/13543784.2013.761205
Singh, P., Agnihotri, A., Pathak, M. K., Shirazi, A., Tiwari, R. P., Sreenivas, V., Sagar, R., & Makharia, G. K. (2012). Psychiatric, somatic and other functional gastrointestinal disorders in patients with irritable bowel syndrome at a tertiary care center. Journal of neurogastroenterology and motility, 18(3), 324–331. https://doi.org/10.5056/jnm.2012.18.3.324
Surdea-Blaga, T., Băban, A., & Dumitrascu, D. L. (2012). Psychosocial determinants of irritable bowel syndrome. World journal of gastroenterology, 18(7), 616–626. https://doi.org/10.3748/wjg.v18.i7.616
Chang L. (2011). The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. Gastroenterology, 140(3), 761–765. https://doi.org/10.1053/j.gastro.2011.01.032
Qin, H. Y., Cheng, C. W., Tang, X. D., & Bian, Z. X. (2014). Impact of psychological stress on irritable bowel syndrome. World journal of gastroenterology, 20(39), 14126–14131. https://doi.org/10.3748/wjg.v20.i39.14126
Wang, B., Duan, R., & Duan, L. (2018). Prevalence of sleep disorder in irritable bowel syndrome: A systematic review with meta-analysis. Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association, 24(3), 141–150. https://doi.org/10.4103/sjg.SJG_603_17
Bellini, M., Gemignani, A., Gambaccini, D., Toti, S., Menicucci, D., Stasi, C., Costa, F., Mumolo, M. G., Ricchiuti, A., Bedini, R., de Bortoli, N., & Marchi, S. (2011). Evaluation of latent links between irritable bowel syndrome and sleep quality. World journal of gastroenterology, 17(46), 5089–5096. https://doi.org/10.3748/wjg.v17.i46.5089
Koloski, N. A., Jones, M., Walker, M. M., Keely, S., Holtmann, G., & Talley, N. J. (2021). Sleep disturbances in the irritable bowel syndrome and functional dyspepsia are independent of psychological distress: a population-based study of 1322 Australians. Alimentary pharmacology & therapeutics, 54(5), 627–636. https://doi.org/10.1111/apt.16500
Hsu, T. Y., He, G. Y., Wang, Y. C., Chen, C. Y., Wang, S. H., Chen, W. K., & Kao, C. H. (2015). Alcohol Use Disorder Increases the Risk of Irritable Bowel Disease: A Nationwide Retrospective Cohort Study. Medicine, 94(51), e2334. https://doi.org/10.1097/MD.0000000000002334
Views:
106
Downloads:
49
Copyright (c) 2025 Piotr Stachura, Bernadetta Wilk, Piotr Rejman, Edyta Witkowska, Marcin Ciechański, Szymon Cholewiński, Klaudia Wilk, Katarzyna Jurkiewicz, Aleksandra Kasprzyk, Katarzyna Pszczoła
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
